key: cord-0853885-vbr6z942 authors: Deshpande, Gururaj Rao; Bhukya, Prudhvi Lal; Yadav, Pragya D; Salunke, Asha; Patil, Chetan; Tilekar, Bipin N; Rakhe, Aparna; Srivastava, Rashi; Gurav, Yogesh K; Potdar, Varsha; Abraham, Priya; Sapkal, Gajanan N title: Comparison of neutralizing antibody response in first and second waves of SARS-CoV-2 pandemic in India date: 2021-12-28 journal: J Travel Med DOI: 10.1093/jtm/taab196 sha: 7302417c25ac13f5c1681dd1c472c06abc3cc0aa doc_id: 853885 cord_uid: vbr6z942 The Delta variant leads to the resurgence of the second wave in India. A 1.51-fold increase in neutralizing antibody response was observed in the second wave compared with first wave, indicating the second wave dominated by the Delta elicited a robust immune response. Mid-September 2020 was associated with a maximal spike in the daily cases in India, with its lowest case load in January 2021 during the first wave with the G Clade (with D614G mutation-B.1) being causal. At the end of first wave, COVID-19 seemed to be restrained, the public became complacent and government relaxed its containment approaches allowing elections and religious gatherings, which lead to the resurgence of the second wave. 2 The Delta variant with 10 mutations in the spike protein seen in the second wave in India (60%) was associated with a surge in the number of cases by May 2021 because of higher transmissibility than the B.1 strain. 2,3 Further, the second wave witnessed greater disease severity and therefore more robust antibody responses, earlier seroconversion (